a phase 2 trial using tranglutaminase 2 inhibitor in celiac disease significant improvement in villous height to crypt depth among intervention group compared to placebo group. Continue reading A potential cure for celiac disease! promising results in a Phase 2 RCT.
The American college of gastroenterology had published the latest UGIB guidelines in January 2021. Although much has not changed, they have considered new evidence from RCT’s published in the last 5 years to make these recommendations. Continue reading Upper G.I bleeding- ACG clinical guideline update.
SARS-CoV2, first started at Wuhan province, china has spread throughout the world, leading to a pandemic, the science here is evolving daily, with new molecules discovered every day and scientists scrambled to investigate new therapies. Continue reading Covid 19 treatment- facts and myths uncovered!
we all know the patients with GERD, most of them are dependant on Proton pump inhibitors (PPI), there are surgeries for these patients who have inadequate response to PPI, how ever, their symptoms usually relapse after 5 to 10 years of surgery. Continue reading A Novel therapy for GERD! data from single centre study shows promising results.
The hepatitis C virus is a bloodborne virus: the most common modes of infection are through exposure to small quantities of blood. This may happen through injection drug use, unsafe injection practices, unsafe health care, transfusion of unscreened blood and blood products, and sexual practices that lead to exposure to blood. Readmore… Continue reading Hepatitis C
Cover image: This transmission electron microscopic (TEM) image revealed the presence of hepatitis B virus (HBV) particles (orange). The round virions, which measure 42nm in diameter, are known as Dane particles. Introduction HBV is a DNA virus, belonging to the … Continue reading Hepatitis B